Company Overview - Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company focused on developing and commercializing therapies for autoimmune diseases [3] - The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody targeting CD19 and FcγRIIb, aimed at inhibiting the activity of B cells involved in autoimmune diseases without depleting them [3] - Zenas aims to leverage its experienced leadership and disciplined product candidate acquisition strategy to identify and develop therapies that provide superior clinical benefits to patients [3] Upcoming Events - Zenas BioPharma will present at the Jefferies Global Healthcare Conference on June 5, 2025, at 1:25 p.m. ET [1] - A live webcast and archived replay of the presentation will be available on the company's website under the "Events and Presentations" section [2]
Zenas BioPharma to Present at the Jefferies Global Healthcare Conference